Sponsor Pipeline

Stelexis BioSciences Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06533761 Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML AML, Adult Recruiting
NCT07231744 Study of STLX-2012 in Healthy Volunteers Healthy Participants Not Yet Recruiting
Disease Areas
Acute Myeloid Leukemia (AML) (1) Myelodysplastic Syndromes (MDS) (1)
Get alerts when Stelexis BioSciences's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free